Literature DB >> 15946186

Chronic GVHD in minor salivary glands and oral mucosa: histopathological and immunohistochemical evaluation of 25 patients.

A B Soares1, P R Faria, L A Magna, M E P Correa, C A de Sousa, O P Almeida, M L Cintra.   

Abstract

BACKGROUND: Graft-vs.-host disease (GVHD) is the major cause of morbidity and mortality in patients undergoing allogeneic Bone Marrow Transplantation (BMT). The aim of our study was to identify the most relevant histological features for diagnosis of chronic Graft-vs.-Host Disease (cGVHD) in oral mucosa and minor salivary glands of 25 patients, as well as to evaluate the immunophenotype of the inflammatory cells.
METHODS: Sixteen patients that were submitted to allogeneic BMT but did not present cGVHD were selected as a control group. The sections were studied on H & E and CD68, CD45, CD4, CD8, CD20 staining.
RESULTS: The most frequent histologic findings in oral mucosa at the day of diagnosis of cGVHD were: hydropic degeneration of the basal layer of the epithelium, apoptotic bodies, lymphocytic infiltration, and focal or total cleavage between the epithelial and connective tissue. In the labial salivary glands (LSG), lymphocytic infiltration, acinar loss and fibrosis were the main alterations. Cytotoxic CD8-T cells and macrophages were predominant both in the epithelium and connective tissue, as well as in minor salivary glands.
CONCLUSIONS: Histological features were useful in the diagnosis of oral cGVHD. It is suggested that CD8-T cells and macrophages play important role in the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15946186     DOI: 10.1111/j.1600-0714.2005.00322.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  15 in total

Review 1.  Oral Complications of Chronic Graft-Versus-Host Disease.

Authors:  Jane M Fall-Dickson; Steven Z Pavletic; Jacqueline W Mays; Mark M Schubert
Journal:  J Natl Cancer Inst Monogr       Date:  2019-08-01

Review 2.  Oral graft-versus-host disease.

Authors:  M M Imanguli; I Alevizos; R Brown; S Z Pavletic; J C Atkinson
Journal:  Oral Dis       Date:  2008-07       Impact factor: 3.511

3.  Oral cGVHD screening tests in the diagnosis of systemic chronic graft-versus-host disease.

Authors:  Renata Gonçalves Resende; Jeane de Fátima Correia-Silva; Telma Cristina Arão; João Artur Ricieri Brito; Henrique Bittencourt; Ricardo Santiago Gomez; Mauro Henrique Nogueira Guimarães Abreu
Journal:  Clin Oral Investig       Date:  2011-03-03       Impact factor: 3.573

4.  Post-allogeneic Hematopoietic Stem Cell Transplantation (HSCT) changes in inorganic salivary components.

Authors:  C C Boer; M E P Correa; L M A Tenuta; C A Souza; A C Vigorito
Journal:  Support Care Cancer       Date:  2015-02-05       Impact factor: 3.603

5.  Simultaneous occurrence of gastric antral vascular ectasia and protein-losing enteropathy in chronic graft-versus-host disease.

Authors:  Masahiro Hirayama; Eiichi Azuma; Atsuko Nakazawa; Shotaro Iwamoto; Hidemi Toyoda; Yoshihiro Komada
Journal:  Int J Hematol       Date:  2013-02-03       Impact factor: 2.490

Review 6.  Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research.

Authors:  J W Mays; H Fassil; D A Edwards; S Z Pavletic; C W Bassim
Journal:  Oral Dis       Date:  2012-10-28       Impact factor: 3.511

7.  Immunohistopathological characterization and the impact of topical immunomodulatory therapy in oral chronic graft-versus-host disease: A pilot study.

Authors:  Acf Motta; Q Zhan; A Larson; M Lerman; S-B Woo; R J Soiffer; G F Murphy; N S Treister
Journal:  Oral Dis       Date:  2018-03-13       Impact factor: 3.511

8.  Proteomic analysis of saliva from patients with oral chronic graft-versus-host disease.

Authors:  Ivana Devic; Min Shi; Mark M Schubert; Michele Lloid; Kenneth T Izutsu; Catherine Pan; Melody Missaghi; Thomas H Morton; Lloyd A Mancl; Jing Zhang; Richard B Presland
Journal:  Biol Blood Marrow Transplant       Date:  2014-04-03       Impact factor: 5.742

9.  Increased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa.

Authors:  Matin M Imanguli; William D Swaim; Stacy C League; Ronald E Gress; Steven Z Pavletic; Frances T Hakim
Journal:  Blood       Date:  2009-01-23       Impact factor: 22.113

Review 10.  Oral carcinoma after hematopoietic stem cell transplantation--a new classification based on a literature review over 30 years.

Authors:  Astrid L D Kruse; Klaus W Grätz
Journal:  Head Neck Oncol       Date:  2009-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.